WuXi Diagnostic Investment (Cayman) Limited announced that it has completed US$150 million in series B funding, joined by new investors including Thermo Fisher Scientific Inc., Shiyu Capital, ABC International Holdings Limited, Sunland Capital and ...
WuXi Diagnostics' researchers and technicians will leverage this facility to optimize existing diagnostic tests and to collaborate in the development of new diagnostic tests with Mayo Clinic's Department of Laboratory Medicine and Pathology, specifically